{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:30:21Z","timestamp":1762864221870,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PCT20\/00018","PT17\/0017"],"award-info":[{"award-number":["PCT20\/00018","PT17\/0017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PTC20\/00018"],"award-info":[{"award-number":["PTC20\/00018"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.rpth.2023.100049","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T11:11:45Z","timestamp":1673694705000},"page":"100049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["No changes in hemostasis after COVID-19\u2013heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-7150","authenticated-orcid":false,"given":"Nora V.","family":"Butta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-5791","authenticated-orcid":false,"given":"Elena G.","family":"Arias-Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-6358","authenticated-orcid":false,"given":"Elena","family":"Monz\u00f3n Manzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0259-8056","authenticated-orcid":false,"given":"Paula","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3296-4288","authenticated-orcid":false,"given":"Mar\u00eda Teresa","family":"\u00c1lvarez Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-889X","authenticated-orcid":false,"given":"Antonio","family":"Bu\u00f1o-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1770-3514","authenticated-orcid":false,"given":"Juan Carlos","family":"Ramos Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3254-7492","authenticated-orcid":false,"given":"Crist\u00f3bal","family":"Belda-Iniesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-9677","authenticated-orcid":false,"given":"Jes\u00fas","family":"Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1823-4174","authenticated-orcid":false,"given":"Antonio J.","family":"Carcas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2941-0922","authenticated-orcid":false,"given":"Luc\u00eda Mart\u00ednez","family":"de Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-818X","authenticated-orcid":false,"given":"Rosa","family":"de Miguel Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Garc\u00eda-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-3263","authenticated-orcid":false,"given":"Alberto M.","family":"Borobia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9450","authenticated-orcid":false,"given":"Jos\u00e9 Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3937-3499","authenticated-orcid":false,"given":"V\u00edctor","family":"Jim\u00e9nez Yuste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.100049_bib1","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100049_bib2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100049_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100049_bib4","first-page":"1599","article-title":"Thrombocytopenia and intracranial venous sinus thrombosis after \"COVID-19 vaccine AstraZeneca\" exposure","volume":"10","author":"Wolf","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.rpth.2023.100049_bib5","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100049_bib6","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2023.100049_bib7","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1161\/STROKEAHA.121.035613","article-title":"Cerebral vein thrombosis with vaccine-induced immune thrombotic thrombocytopenia","volume":"52","author":"Siegler","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2023.100049_bib8","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100049_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00956-2021","article-title":"Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase","volume":"58","author":"Smadja","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rpth.2023.100049_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(21)01420-3","article-title":"Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"398","author":"Borobia","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100049_bib11","article-title":"Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic COVID-19 infection in Sweden: a nationwide cohort study","volume":"11","author":"Nordstrom","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.rpth.2023.100049_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.arbres.2020.11.017","article-title":"Procoagulant state of sleep apnea depends on systemic inflammation and endothelial damage","volume":"58","author":"Fernandez-Bello","year":"2022","journal-title":"Archivos de Bronconeumologia"},{"key":"10.1016\/j.rpth.2023.100049_bib13","first-page":"3297","article-title":"Insights into the procoagulant profile of patients with systemic lupus erythematosus without antiphospholipid antibodies","volume":"9","author":"Monzon Manzano","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.rpth.2023.100049_bib14","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/CIRCULATIONAHA.106.635169","article-title":"Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population","volume":"115","author":"Rudnicka","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2023.100049_bib15","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1055\/a-1535-9002","article-title":"PF4-dependent immunoassays in patients with vaccine-induced immune thrombotic thrombocytopenia: results of an interlaboratory comparison","volume":"121","author":"Sachs","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100049_bib16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2023.100049_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(21)01694-9","article-title":"Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial","volume":"398","author":"Liu","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100049_bib18","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100049_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-04120-y","article-title":"Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination","volume":"600","author":"Pozzetto","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.rpth.2023.100049_bib20","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41591-021-01464-w","article-title":"Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19\/mRNA vaccination","volume":"27","author":"Schmidt","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.rpth.2023.100049_bib21","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/S0140-6736(21)01115-6","article-title":"Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data","volume":"397","author":"Shaw","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100049_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12529","article-title":"Vaccine-induced Immune thrombocytopenia and thrombosis (VITT)","volume":"5","author":"Makris","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100049_bib23","first-page":"355","article-title":"Addressing vaccine-induced immune thrombotic thrombocytopenia (vitt) following COVID-19 vaccination: a mini-review of practical strategies","volume":"37","author":"Chen","year":"2021","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.rpth.2023.100049_bib24","article-title":"Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: a national cohort study in England","volume":"13","author":"Andrews","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.rpth.2023.100049_bib25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100049_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.seminhematol.2022.02.002","article-title":"Epidemiology of VITT","volume":"59","author":"Pai","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.rpth.2023.100049_bib27","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2021014214","article-title":"Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient","volume":"139","author":"Schonborn","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100049_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1309\/AJCPG0MNR5NGKNFX","article-title":"Platelet factor 4\/heparin antibodies in blood bank donors","volume":"134","author":"Hursting","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rpth.2023.100049_bib29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/vaccines9070712","article-title":"High prevalence of anti-PF4 antibodies following ChAdOx1 nCov-19 (AZD1222) vaccination even in the absence of thrombotic events","volume":"9","author":"Terpos","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.rpth.2023.100049_bib30","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.2021012064","article-title":"A\u00a0flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"Handtke","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100049_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100049_bib32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/ijlh.13774","article-title":"Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine","volume":"44","author":"Barefah","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2023.100049_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rpth.2023.100049_bib34","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100049_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2019.11.030","article-title":"Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?","volume":"186","author":"Medeiros","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100049_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ijlh.13629","article-title":"Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia","volume":"43","author":"Favaloro","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2023.100049_bib37","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1055\/a-1788-5206","article-title":"Assessing clinically meaningful hypercoagulability after COVID-19 vaccination: a longitudinal study","volume":"122","author":"Campello","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100049_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.966028","article-title":"Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S","volume":"9","author":"de Laat","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2023.100049_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102685","article-title":"Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: an analysis of European data","volume":"122","author":"Cari","year":"2021","journal-title":"J\u00a0Autoimmun"},{"unstructured":"EMA E. ECDC recommendations on heterologous vaccination courses against COVID-19: \u2018mix-and-match\u2019 approach can be used for both initial courses and boosters.\u00a02021.","key":"10.1016\/j.rpth.2023.100049_bib40"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:23:16Z","timestamp":1762863796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2475037923000146"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100049","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No changes in hemostasis after COVID-19\u2013heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"100049"}}